Advertisement

Index by author

January 01, 1985; Volume 13,Issue 1

A

  1. Adams, E A

    1. Metabolites of phenanthridine formed by rat liver homogenate.
      E J LaVoie, E A Adams, A Shigematsu and D Hoffmann
      Drug Metabolism and Disposition January 1985, 13 (1) 71-75;

  2. Armand, J P

    1. Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
      R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
      Drug Metabolism and Disposition January 1985, 13 (1) 116-118;

B

  1. Baillie, T A

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  2. Benet, L Z

    1. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
      P C Smith, J Hasegawa, P N Langendijk and L Z Benet
      Drug Metabolism and Disposition January 1985, 13 (1) 110-112;

  3. Bernadou, J

    1. Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
      R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
      Drug Metabolism and Disposition January 1985, 13 (1) 116-118;

  4. Billings, R E

    1. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.
      K S Pang, P Kong, J A Terrell and R E Billings
      Drug Metabolism and Disposition January 1985, 13 (1) 42-50;

  5. Birnbaum, L S

    1. Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung, and kidney of male Fischer rats.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition January 1985, 13 (1) 62-67;
    2. Disposition of benzo(f)quinoline in male rats.
      L S Birnbaum and L Johnson
      Drug Metabolism and Disposition January 1985, 13 (1) 18-24;

  6. Bjorge, S M

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  7. Bockbrader, H N

    1. Formation of [20R]-dihydrodigoxin from digoxin in humans.
      R H Reuning, T A Shepard, B E Morrison and H N Bockbrader
      Drug Metabolism and Disposition January 1985, 13 (1) 51-57;

  8. Borghoff, S J

    1. Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung, and kidney of male Fischer rats.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition January 1985, 13 (1) 62-67;

C

  1. Chang, S L

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  2. Chatterji, D C

    1. 4,5-beta-dihydrotestolactone: metabolite identification with the aid of the attached proton test in carbon-13 NMR.
      R L Yeager, V L Pascucci, D C Chatterji and B A Mico
      Drug Metabolism and Disposition January 1985, 13 (1) 107-109;

  3. Chiueh, C C

    1. Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
      C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
      Drug Metabolism and Disposition January 1985, 13 (1) 1-4;

  4. Chung, M

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;

  5. Counsell, R E

    1. In vitro and in vivo metabolism of a radioiodinated analog of 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,-dichloroethane.
      R C Pohland and R E Counsell
      Drug Metabolism and Disposition January 1985, 13 (1) 113-115;

D

  1. D'Ambrosio, S M

    1. Metabolism of 7,12-dimethylbenz(a)anthracene and its DNA adduct formation in human fetal kidney and intestinal cells in culture.
      C T Oravec, M J Samuel and S M D'Ambrosio
      Drug Metabolism and Disposition January 1985, 13 (1) 76-80;

  2. Dills, R L

    1. A radiometric method for the measurement of adenosine 3'-phosphate 5'-phosphosulfate in rat and mouse liver.
      G A Hazelton, J J Hjelle, R L Dills and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 30-34;

F

  1. Finley, B L

    1. Stereoselective glucuronidation as a probe of induced forms of UDP-glucuronyltransferase in rabbits.
      G S Yost and B L Finley
      Drug Metabolism and Disposition January 1985, 13 (1) 5-8;

G

  1. Gordon, W P

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  2. Greenblatt, D J

    1. Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
      C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
      Drug Metabolism and Disposition January 1985, 13 (1) 1-4;

  3. Gural, R

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;

H

  1. Hanano, M

    1. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
      Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
      Drug Metabolism and Disposition January 1985, 13 (1) 102-106;

  2. Hasegawa, J

    1. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
      P C Smith, J Hasegawa, P N Langendijk and L Z Benet
      Drug Metabolism and Disposition January 1985, 13 (1) 110-112;

  3. Hazelton, G A

    1. Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 68-70;
    2. A radiometric method for the measurement of adenosine 3'-phosphate 5'-phosphosulfate in rat and mouse liver.
      G A Hazelton, J J Hjelle, R L Dills and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 30-34;
    3. Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 35-41;

  4. Hilbert, J M

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;

  5. Hjelle, J J

    1. Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 68-70;
    2. A radiometric method for the measurement of adenosine 3'-phosphate 5'-phosphosulfate in rat and mouse liver.
      G A Hazelton, J J Hjelle, R L Dills and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 30-34;
    3. Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 35-41;

  6. Hoffmann, D

    1. Metabolites of phenanthridine formed by rat liver homogenate.
      E J LaVoie, E A Adams, A Shigematsu and D Hoffmann
      Drug Metabolism and Disposition January 1985, 13 (1) 71-75;

I

  1. Iga, T

    1. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
      Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
      Drug Metabolism and Disposition January 1985, 13 (1) 102-106;

  2. Igari, Y

    1. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
      Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
      Drug Metabolism and Disposition January 1985, 13 (1) 102-106;

J

  1. Johnson, L

    1. Disposition of benzo(f)quinoline in male rats.
      L S Birnbaum and L Johnson
      Drug Metabolism and Disposition January 1985, 13 (1) 18-24;

  2. Jonas, L A

    1. Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
      C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
      Drug Metabolism and Disposition January 1985, 13 (1) 1-4;

K

  1. Kedderis, G L

    1. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
      G L Kedderis and D E Rickert
      Drug Metabolism and Disposition January 1985, 13 (1) 58-61;

  2. Klaassen, C D

    1. Increased UDP-glucuronosyltransferase activity and UDP-glucuronic acid concentration in the small intestine of butylated hydroxyanisole-treated mice.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 68-70;
    2. A radiometric method for the measurement of adenosine 3'-phosphate 5'-phosphosulfate in rat and mouse liver.
      G A Hazelton, J J Hjelle, R L Dills and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 30-34;
    3. Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.
      J J Hjelle, G A Hazelton and C D Klaassen
      Drug Metabolism and Disposition January 1985, 13 (1) 35-41;

  3. Klippert, P J

    1. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
      P J Klippert and J Noordhoek
      Drug Metabolism and Disposition January 1985, 13 (1) 97-101;

  4. Kong, P

    1. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.
      K S Pang, P Kong, J A Terrell and R E Billings
      Drug Metabolism and Disposition January 1985, 13 (1) 42-50;

L

  1. Lang, C A

    1. Aging effects on acetaminophen toxicity and glutathione status in the mosquito.
      J P Richie and C A Lang
      Drug Metabolism and Disposition January 1985, 13 (1) 14-17;

  2. Langendijk, P N

    1. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
      P C Smith, J Hasegawa, P N Langendijk and L Z Benet
      Drug Metabolism and Disposition January 1985, 13 (1) 110-112;

  3. LaVoie, E J

    1. Metabolites of phenanthridine formed by rat liver homogenate.
      E J LaVoie, E A Adams, A Shigematsu and D Hoffmann
      Drug Metabolism and Disposition January 1985, 13 (1) 71-75;

  4. Levy, R H

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  5. Lopez, A

    1. Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
      R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
      Drug Metabolism and Disposition January 1985, 13 (1) 116-118;

M

  1. Malet-Martino, M C

    1. Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
      R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
      Drug Metabolism and Disposition January 1985, 13 (1) 116-118;

  2. Martino, R

    1. Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
      R Martino, A Lopez, M C Malet-Martino, J Bernadou and J P Armand
      Drug Metabolism and Disposition January 1985, 13 (1) 116-118;

  3. Mico, B A

    1. 4,5-beta-dihydrotestolactone: metabolite identification with the aid of the attached proton test in carbon-13 NMR.
      R L Yeager, V L Pascucci, D C Chatterji and B A Mico
      Drug Metabolism and Disposition January 1985, 13 (1) 107-109;

  4. Morrison, B E

    1. Formation of [20R]-dihydrodigoxin from digoxin in humans.
      R H Reuning, T A Shepard, B E Morrison and H N Bockbrader
      Drug Metabolism and Disposition January 1985, 13 (1) 51-57;

N

  1. Ning, J

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;

  2. Noordhoek, J

    1. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
      P J Klippert and J Noordhoek
      Drug Metabolism and Disposition January 1985, 13 (1) 97-101;

O

  1. Ohata, M

    1. Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
      C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
      Drug Metabolism and Disposition January 1985, 13 (1) 1-4;

  2. Oravec, C T

    1. Metabolism of 7,12-dimethylbenz(a)anthracene and its DNA adduct formation in human fetal kidney and intestinal cells in culture.
      C T Oravec, M J Samuel and S M D'Ambrosio
      Drug Metabolism and Disposition January 1985, 13 (1) 76-80;

P

  1. Pang, K S

    1. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.
      K S Pang, P Kong, J A Terrell and R E Billings
      Drug Metabolism and Disposition January 1985, 13 (1) 42-50;

  2. Pascucci, V L

    1. 4,5-beta-dihydrotestolactone: metabolite identification with the aid of the attached proton test in carbon-13 NMR.
      R L Yeager, V L Pascucci, D C Chatterji and B A Mico
      Drug Metabolism and Disposition January 1985, 13 (1) 107-109;

  3. Pohland, R C

    1. In vitro and in vivo metabolism of a radioiodinated analog of 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,-dichloroethane.
      R C Pohland and R E Counsell
      Drug Metabolism and Disposition January 1985, 13 (1) 113-115;

  4. Prickett, K S

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

R

  1. Rapoport, S I

    1. Brain uptake of flurazepam and of N1-desalkyl flurazepam after administration of flurazepam to the cat.
      C C Chiueh, M Ohata, L A Jonas, D J Greenblatt and S I Rapoport
      Drug Metabolism and Disposition January 1985, 13 (1) 1-4;

  2. Rettenmeier, A W

    1. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
      A W Rettenmeier, K S Prickett, W P Gordon, S M Bjorge, S L Chang, R H Levy and T A Baillie
      Drug Metabolism and Disposition January 1985, 13 (1) 81-96;

  3. Reuning, R H

    1. Formation of [20R]-dihydrodigoxin from digoxin in humans.
      R H Reuning, T A Shepard, B E Morrison and H N Bockbrader
      Drug Metabolism and Disposition January 1985, 13 (1) 51-57;

  4. Richie, J P

    1. Aging effects on acetaminophen toxicity and glutathione status in the mosquito.
      J P Richie and C A Lang
      Drug Metabolism and Disposition January 1985, 13 (1) 14-17;

  5. Rickert, D E

    1. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
      G L Kedderis and D E Rickert
      Drug Metabolism and Disposition January 1985, 13 (1) 58-61;

S

  1. Samuel, M J

    1. Metabolism of 7,12-dimethylbenz(a)anthracene and its DNA adduct formation in human fetal kidney and intestinal cells in culture.
      C T Oravec, M J Samuel and S M D'Ambrosio
      Drug Metabolism and Disposition January 1985, 13 (1) 76-80;

  2. Sawada, Y

    1. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
      Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
      Drug Metabolism and Disposition January 1985, 13 (1) 102-106;

  3. Shepard, T A

    1. Formation of [20R]-dihydrodigoxin from digoxin in humans.
      R H Reuning, T A Shepard, B E Morrison and H N Bockbrader
      Drug Metabolism and Disposition January 1985, 13 (1) 51-57;

  4. Shigematsu, A

    1. Metabolites of phenanthridine formed by rat liver homogenate.
      E J LaVoie, E A Adams, A Shigematsu and D Hoffmann
      Drug Metabolism and Disposition January 1985, 13 (1) 71-75;

  5. Smith, P C

    1. Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.
      P C Smith, J Hasegawa, P N Langendijk and L Z Benet
      Drug Metabolism and Disposition January 1985, 13 (1) 110-112;

  6. Sugiyama, Y

    1. Kinetics of receptor occupation and anticonvulsive effects of diazepam in rats.
      Y Igari, Y Sugiyama, Y Sawada, T Iga and M Hanano
      Drug Metabolism and Disposition January 1985, 13 (1) 102-106;

  7. Symchowicz, S

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;

T

  1. Terrell, J A

    1. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.
      K S Pang, P Kong, J A Terrell and R E Billings
      Drug Metabolism and Disposition January 1985, 13 (1) 42-50;

V

  1. Virgo, B B

    1. Effects of somatostatin and testosterone on the hepatic monooxygenase system in castrated male rats.
      B B Virgo
      Drug Metabolism and Disposition January 1985, 13 (1) 9-13;

Y

  1. Yeager, R L

    1. 4,5-beta-dihydrotestolactone: metabolite identification with the aid of the attached proton test in carbon-13 NMR.
      R L Yeager, V L Pascucci, D C Chatterji and B A Mico
      Drug Metabolism and Disposition January 1985, 13 (1) 107-109;

  2. Yost, G S

    1. Stereoselective glucuronidation as a probe of induced forms of UDP-glucuronyltransferase in rabbits.
      G S Yost and B L Finley
      Drug Metabolism and Disposition January 1985, 13 (1) 5-8;

Z

  1. Zampaglione, N

    1. Disposition and metabolic fate of 14C-quazepam in man.
      N Zampaglione, J M Hilbert, J Ning, M Chung, R Gural and S Symchowicz
      Drug Metabolism and Disposition January 1985, 13 (1) 25-29;
Back to top

In this issue